Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study활동적으로 치료받고 있는 암 환자에서 SARS-CoV-2 mRNA-BNT162b2 백신의 세 번째 접종 후 대상포진: 전향적 연구Article Published on 2024-01-202024-08-16 Journal: Clin Exp Med [Category] 대상포진, [키워드] active treatment COVID-19 vaccine herpes zoster SARS-CoV-2 solid tumors T cell third dose
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective studyResearch Published on 2024-01-202024-09-05 Journal: Clinical and experimental medicine [Category] update2024, [키워드] active treatment COVID-19 vaccine herpes zoster SARS-CoV-2 solid tumors T cell third dose [DOI] 10.1007/s10238-023-01263-2 PMC 바로가기 [Article Type] Research
Safety and Efficacy of a Third Dose of the BNT162b2 Vaccine in Liver-Transplanted and Healthy AdolescentsHepatology Published on 2023-11-092024-09-05 Journal: Jpgn Reports [Category] update2024, [키워드] Adolescent BNT162b2 booster Coronavirus disease 2019 liver transplant third dose [DOI] 10.1097/PG9.0000000000000373 PMC 바로가기 [Article Type] Hepatology
Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodiesShort Communication Published on 2023-01-302024-09-05 Journal: Vaccine [Category] update2024, [키워드] COVID-19 Hematological malignancies Immunocompromised T cell responses third dose Vaccine [DOI] 10.1016/j.vaccine.2023.01.064 PMC 바로가기 [Article Type] Short Communication
Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant waveArticle Published on 2023-01-222024-09-05 Journal: International Journal of Infectious Diseases [Category] update2024, [키워드] Breakthrough infection COVID-19 neutralizing antibody omicron third dose [DOI] 10.1016/j.ijid.2023.01.023 PMC 바로가기 [Article Type] Article
Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controlsArticle Published on 2022-12-092023-07-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), [키워드] Comorbidities COVID-19 vaccine Humoral response solid organ transplant third dose [DOI] 10.3389/fimmu.2022.1039245 PMC 바로가기
Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIVArticle Published on 2022-12-012023-07-10 Journal: The Journal of Infection [Category] COVID19(2023년), [키워드] Antibody responses Breakthrough infection cellular COVID-19 vaccine HIV humoral immune response neutralisation omicron people living with HIV SARS-CoV-2 mRNA vaccine third dose [DOI] 10.1016/j.jinf.2022.09.006 PMC 바로가기
Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, randomized clinical trialRandomized Controlled Trial Published on 2022-12-012023-07-10 Journal: Journal of Clinical Virology [Category] COVID19(2023년), [키워드] COVID-19 heterologous booster immunogenicity Safety third dose Vaccine [DOI] 10.1016/j.jcv.2022.105328 PMC 바로가기 [Article Type] Randomized Controlled Trial
The association between social media use and hesitancy toward COVID-19 vaccine booster shots in China: A web-based cross-sectional survey중국에서 소셜 미디어 사용과 COVID-19 백신 부스터 접종에 대한 주저의 연관성: 웹 기반 횡단면 조사Article Published on 2022-11-302022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted odds ratio association booster booster shot China conducted content COVID-19 COVID-19 vaccine cross-sectional cross-sectional study cross-sectional survey effort evaluate health information Hesitancy hesitancy rate Immunity information knowledge media misinformation monthly income participant platform questionnaire regulate response rate SARS-CoV-2 variants social media third dose unemployment Vaccine Vaccine hesitancy [DOI] 10.1080/21645515.2022.2065167 PMC 바로가기 [Article Type] Article
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipientsArticle Published on 2022-10-192022-11-15 Journal: Vaccine [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] age anti-spike antibody antibodies Antibody titer booster conducted COVID-19 COVID-19 vaccine detectable dose doses fourth dose had more humoral immune response IQR kidney transplant recipients liver transplant no statistical difference Organ transplant participant patients proportion receiving recipient recipients regimen retrospective SARS-CoV-2 SARS-CoV-2 vaccine significantly higher solid-organ transplant Solid-organ transplantation SOT tested third dose vaccination Vaccine vaccine doses vaccine injection [DOI] 10.1016/j.vaccine.2022.08.065 PMC 바로가기